LXEO Lexeo Therapeutics, Inc.
Nasdaq · SEC CIK 1907108 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $985.2K 22 sales by 7 insiders
- Filings on record
- 96 since 2023-11-09, latest 2026-08-19 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| Tamayo Louis Edward | CFO | — | $41.0K |
| See Tai Sandi | Chief Development Off | — | $38.4K |
| Robertson Jenny | CLO | — | $36.6K |
| Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 92
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Tamayo Louis Edward | CFO | S - Sale | $4.91 | -4,117 | 92.9K | -4% | -$20.2K | |
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.95 | -3,345 | 374.5K | -0.9% | -$16.6K | |
| 2026-08-19 17:00 | 2026-08-18 | LXEO | Otero Jose Manuel | COO | S - Sale | $4.96 | -1,304 | 136.2K | -0.9% | -$6,464 | |
| 2026-07-01 18:49 | 2026-06-29 | LXEO | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +12.0K | 101.7K | +13% | $0 | |
| 2026-07-01 18:49 | 2026-07-01 | LXEO | Tamayo Louis Edward | CFO | S - Sale | $4.49 | -4,641 | 97.0K | -5% | -$20.8K | |
| 2026-07-01 18:49 | 2026-06-29 | LXEO | Otero Jose Manuel | COO | A - Grant | $0.00 | +12.1K | 142.1K | +9% | $0 | |
| 2026-07-01 18:49 | 2026-07-01 | LXEO | Otero Jose Manuel | COO | S - Sale | $4.48 | -4,666 | 137.5K | -3% | -$20.9K | |
| 2026-07-01 18:48 | 2026-06-29 | LXEO | Bhalla Narinder Pal | Chief Medical Off | A - Grant | $0.00 | +55.0K | 104.5K | +111% | $0 | |
| 2026-07-01 18:48 | 2026-07-01 | LXEO | Bhalla Narinder Pal | Chief Medical Off | S - Sale | $4.42 | -22.3K | 82.2K | -21% | -$98.6K | |
| 2026-07-01 18:47 | 2026-06-29 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +67.0K | 403.8K | +20% | $0 | |
| 2026-07-01 18:47 | 2026-07-01 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.48 | -25.9K | 377.8K | -6% | -$116.2K | |
| 2026-05-20 16:30 | 2026-05-18 | LXEO | Otero Jose Manuel | COO | S - Sale | $5.07 | -1,302 | 130.1K | -1.0% | -$6,606 | |
| 2026-05-20 16:30 | 2026-05-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $5.06 | -3,342 | 336.8K | -1.0% | -$16.9K | |
| T | 2026-04-07 16:55 | 2026-04-06 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $5.69 | -55.0K | 340.1K | -14% | -$313.1K |
| 2026-03-17 | 2026-03-13 | LXEO | Otero Jose Manuel | COO | A - Grant | $2.64 | +5,930 | 131.4K | +5% | +$15.7K | |
| 2026-03-17 | 2026-03-13 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.64 | +2,623 | 395.1K | +0.7% | +$6,925 | |
| 2026-02-20 | 2026-02-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $6.38 | -10.2K | 392.5K | -3% | -$64.9K | |
| A | 2026-02-20 | 2025-11-18 | LXEO | Otero Jose Manuel | COO | S - Sale | $9.27 | -721 | 63.5K | -1% | -$6,684 |
| 2026-02-20 | 2026-02-18 | LXEO | Otero Jose Manuel | COO | S - Sale | $6.40 | -3,016 | 125.5K | -2% | -$19.3K | |
| D | 2026-02-17 | 2026-02-13 | LXEO | Bhalla Narinder Pal | Chief Medical Off | A - Grant | $0.00 | +49.5K | 49.5K | New | $0 |
| D | 2026-02-06 | 2026-02-04 | LXEO | Otero Jose Manuel | COO | A - Grant | $0.00 | +65.0K | 128.5K | +102% | $0 |
| D | 2026-02-06 | 2026-02-04 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +161.7K | 402.7K | +67% | $0 |
| D | 2026-02-06 | 2026-02-04 | LXEO | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +44.7K | 89.7K | +99% | $0 |
| 2025-11-20 | 2025-08-18 | LXEO | Otero Jose Manuel | Chief Technical Off | S - Sale | $9.27 | -721 | 63.5K | -1% | -$6,684 | |
| 2025-11-20 | 2025-11-18 | LXEO | Robertson Jenny | CLO | S - Sale | $9.27 | -549 | 68.4K | -0.8% | -$5,089 | |
| 2025-11-20 | 2025-11-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $9.27 | -1,127 | 241.0K | -0.5% | -$10.4K | |
| 2025-11-20 | 2025-11-18 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $9.27 | -615 | 72.6K | -0.8% | -$5,701 | |
| 2025-11-20 | 2025-11-18 | LXEO | See Tai Sandi | Chief Development Off | S - Sale | $9.27 | -386 | 65.5K | -0.6% | -$3,578 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Robertson Jenny | CLO | S - Sale | $8.95 | -3,526 | 69.0K | -5% | -$31.5K |
| 2025-10-17 | 2025-10-15 | LXEO | Robertson Jenny | CLO | A - Grant | $0.00 | +9,900 | 72.5K | +16% | $0 | |
| 2025-10-17 | 2025-10-15 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +33.0K | 255.3K | +15% | $0 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $8.95 | -13.1K | 242.1K | -5% | -$117.5K |
| M | 2025-10-17 | 2025-10-17 | LXEO | Otero Jose Manuel | Chief Technical Off | S - Sale | $8.95 | -2,115 | 64.2K | -3% | -$18.9K |
| 2025-10-17 | 2025-10-15 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +5,940 | 66.3K | +10% | $0 | |
| 2025-10-17 | 2025-10-15 | LXEO | See Tai Sandi | Chief Development Off | A - Grant | $0.00 | +10.9K | 69.8K | +19% | $0 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | See Tai Sandi | Chief Development Off | S - Sale | $8.95 | -3,888 | 65.9K | -6% | -$34.8K |
| 2025-10-17 | 2025-10-15 | LXEO | Adler Eric | Chief Medical Off | A - Grant | $0.00 | +9,570 | 76.6K | +14% | $0 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $8.95 | -3,382 | 73.3K | -4% | -$30.3K |
| 2025-09-16 | 2025-09-12 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.64 | +2,193 | 222.3K | +1.0% | +$5,790 | |
| A | 2025-09-10 | 2025-08-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.67 | -1,115 | 220.1K | -0.5% | -$5,207 |
| D | 2025-09-03 | 2025-08-29 | LXEO | Tamayo Louis Edward | CFO | A - Grant | $0.00 | +45.0K | 45.0K | New | $0 |
| 2025-08-20 | 2025-08-18 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $4.67 | -608 | 67.1K | -0.9% | -$2,839 | |
| 2025-08-20 | 2025-08-18 | LXEO | Robertson Jenny | CLO | S - Sale | $4.67 | -542 | 62.6K | -0.9% | -$2,531 | |
| 2025-08-20 | 2025-08-18 | LXEO | Otero Jose Manuel | Chief Technical Off | S - Sale | $4.67 | -2,848 | 60.4K | -5% | -$13.3K | |
| 2025-08-20 | 2025-08-18 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.67 | -2,735 | 220.1K | -1% | -$12.8K | |
| 2025-08-20 | 2025-08-18 | LXEO | See Tai Sandi | Chief Development Off | S - Sale | $4.67 | -382 | 58.9K | -0.6% | -$1,784 | |
| 2025-05-20 | 2025-05-16 | LXEO | See Tai Sandi | Chief Development Off | S - Sale | $2.77 | -367 | 59.2K | -0.6% | -$1,017 | |
| 2025-05-20 | 2025-05-16 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $2.77 | -1,074 | 221.2K | -0.5% | -$2,975 | |
| 2025-05-20 | 2025-05-16 | LXEO | Robertson Jenny | CLO | S - Sale | $2.77 | -521 | 63.1K | -0.8% | -$1,443 | |
| 2025-05-20 | 2025-05-16 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $2.77 | -585 | 67.7K | -0.9% | -$1,620 | |
| 2025-04-09 | 2025-03-14 | LXEO | See Tai Sandi | Chief Development Off | A - Grant | $2.61 | +5,720 | 59.6K | +11% | +$14.9K | |
| 2025-04-09 | 2025-03-14 | LXEO | Robertson Jenny | CLO | A - Grant | $2.61 | +5,720 | 63.6K | +10% | +$14.9K | |
| 2025-04-09 | 2025-03-14 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $2.61 | +5,720 | 63.2K | +10% | +$14.9K | |
| 2025-04-01 | 2025-03-14 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $2.61 | +2,128 | 222.2K | +1.0% | +$5,554 | |
| 2025-02-21 | 2025-02-19 | LXEO | See Tai Sandi | Chief Development Off | S - Sale | $4.41 | -1,486 | 53.9K | -3% | -$6,553 | |
| 2025-02-21 | 2025-02-19 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale | $4.41 | -4,326 | 220.1K | -2% | -$19.1K | |
| 2025-02-21 | 2025-02-19 | LXEO | Robertson Jenny | CLO | S - Sale | $4.41 | -2,101 | 57.9K | -4% | -$9,265 | |
| 2025-02-21 | 2025-02-19 | LXEO | Adler Eric | Chief Medical Off | S - Sale | $4.41 | -2,359 | 68.3K | -3% | -$10.4K | |
| D | 2025-01-22 | 2025-01-17 | LXEO | Rasbach Kyle | CFO | A - Grant | $0.00 | +40.9K | 40.9K | New | $0 |
| D | 2025-01-10 | 2025-01-07 | LXEO | Adler Eric | Chief Medical Off | A - Grant | $0.00 | +43.8K | 70.6K | +163% | $0 |
| D | 2025-01-10 | 2025-01-07 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +26.2K | 57.5K | +84% | $0 |
| D | 2025-01-10 | 2025-01-07 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +103.8K | 224.4K | +86% | $0 |
| D | 2025-01-10 | 2025-01-07 | LXEO | See Tai Sandi | Chief Development Off | A - Grant | $0.00 | +38.8K | 55.4K | +233% | $0 |
| D | 2025-01-10 | 2025-01-07 | LXEO | Robertson Jenny | Chief Legal, Admin Off | A - Grant | $0.00 | +36.2K | 60.0K | +153% | $0 |
| D | 2024-12-12 | 2024-12-10 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +2,500 | 123.2K | +2% | +$5,825 |
| D | 2024-12-12 | 2024-12-10 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $8.20 | -2,500 | 120.7K | -2% | -$20.5K |
| 2024-11-26 | 2024-11-25 | LXEO | CHOLMONDELEY PAULA H | Dir | P - Purchase | $6.99 | +15.0K | 30.6K | +96% | +$104.8K | |
| D | 2024-11-13 | 2024-11-11 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $7.82 | -2,500 | 120.7K | -2% | -$19.6K |
| D | 2024-11-13 | 2024-11-11 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +2,500 | 123.2K | +2% | +$5,825 |
| D | 2024-10-15 | 2024-10-10 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-10-15 | 2024-10-10 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $8.10 | -5,000 | 120.7K | -4% | -$40.5K |
| D | 2024-09-11 | 2024-09-10 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $10.65 | -5,000 | 120.7K | -4% | -$53.2K |
| D | 2024-09-11 | 2024-09-10 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-08-13 | 2024-08-12 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $11.53 | -5,000 | 120.7K | -4% | -$57.6K |
| D | 2024-08-13 | 2024-08-12 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 125.7K | +4% | +$11.7K |
| D | 2024-07-12 | 2024-07-10 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| DM | 2024-07-12 | 2024-07-10+ | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $16.79 | -55.0K | 148.7K | -27% | -$923.4K |
| DT | 2024-06-14 | 2024-06-12 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +31.2K | 31.2K | New | $0 |
| D | 2024-06-12 | 2024-06-10 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| DM | 2024-06-12 | 2024-06-10 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $17.65 | -5,000 | 170.7K | -3% | -$88.3K |
| DT | 2024-05-14 | 2024-05-13 | LXEO | Townsend Richard Nolan | CEO, Dir | S - Sale+OE | $13.22 | -5,000 | 170.7K | -3% | -$66.1K |
| DT | 2024-05-14 | 2024-05-13 | LXEO | Townsend Richard Nolan | CEO, Dir | M - OptEx | $2.33 | +5,000 | 175.7K | +3% | +$11.7K |
| D | 2024-02-06 | 2024-02-02 | LXEO | Adler Eric | Chief Medical Off | A - Grant | $0.00 | +26.9K | 26.9K | New | $0 |
| DT | 2024-01-09 | 2024-01-05 | LXEO | Townsend Richard Nolan | CEO, Dir | A - Grant | $0.00 | +43.8K | 170.7K | +34% | $0 |
| DT | 2024-01-09 | 2024-01-05 | LXEO | Robertson Jenny | Chief Legal, Admin Off | A - Grant | $0.00 | +23.8K | 23.8K | New | $0 |
| DM | 2023-11-09 | 2023-11-07 | LXEO | Paster Anne-Mari | 10% | C - Cnv Deriv | — | +1.70M | 1.70M | New | — |
| D | 2023-11-09 | 2023-11-07 | LXEO | Paster Anne-Mari | 10% | P - Purchase | $11.00 | +454.5K | 2.16M | +27% | +$5.00M |
| DM | 2023-11-09 | 2023-11-07 | LXEO | Lundbeckfond Invest A/S | 10% | C - Cnv Deriv | — | +1.61M | 1.32M | New | — |
| D | 2023-11-09 | 2023-11-07 | LXEO | Lundbeckfond Invest A/S | 10% | P - Purchase | $11.00 | +227.3K | 1.84M | +14% | +$2.50M |
| DI | 2023-11-09 | 2023-11-07 | LXEO | Longitude Venture Partners IV, L.P. | 10% | P - Purchase | $11.00 | +454.5K | 2.57M | +22% | +$5.00M |
| DMI | 2023-11-09 | 2023-11-07 | LXEO | Longitude Venture Partners IV, L.P. | 10% | C - Cnv Deriv | — | +2.11M | 1.79M | New | — |
| D | 2023-11-09 | 2023-11-07 | LXEO | McCormac Paul | Chief Technical Off | C - Cnv Deriv | — | +3,191 | 17.3K | +23% | — |
Purchase Sale Sale after option exercise All abbreviations